The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 1 Distribution of studied patients according to baseline data

From: Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as predictors of MS severity: a retrospective cohort study

	Mean ± SD	Range
Age (year)	33.1 ± 6.55	20–48
Age of onset (year)	29.21 ± 6.07	18–42
EDSS	2.93 ± 0.86	1.5–4
	n = 150	%
Sex
Male	60	40%
Female	90	60%
BMI (kg/m²)	28.65 ± 4.75	20–34.5
DMT	100	66.7%
Type
PPMS	10	6.7%
RRMS	140	93.3%
Relapse
Two	40	28.6%
Three	50	35.7%
Four	20	14.3%
Five	30	21.4%
Hematocrit	40.34 ± 2.78	36–44
NLR	2.69 ± 0.43	2.0–3.4
WBCs	6.16 ± 1.61	4.3–9.8
Platelet count	257.53 ± 45.19	191–354
PLR	191.03 ± 40.19	140–256
EDSS		73.3%
Mild	110	26.7%
Moderate and severe	40
MLR	0.23 ± 0.04	0.17–0.33

EDSS extended disability status scale, BMI body mass index, DMT disease-modifying therapy, PPMS primary progressive multiple sclerosis, RRMS relapsing–remitting multiple sclerosis, NLR neutrophil–lymphocyte ratio, WBCs white blood cells, PLR platelet–lymphocyte ratio, MLR monocyte–lymphocyte ratio

Back to article page